NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.82 -0.54 (-0.65%) GOLD FUTURES
2,332.90 -9.20 (-0.39%) DOW
38,432.80 -70.89 (-0.18%) Bitcoin GBP
51,565.23 -2,018.02 (-3.77%)
AVROBIO, Inc. (AVRO)
| Previous close | 1.2100 |
| Open | 1.1900 |
| Bid | 1.1800 x 400 |
| Ask | 1.2000 x 100 |
| Day's range | 1.1900 - 1.2100 |
| 52-week range | 0.5700 - 1.7000 |
| Volume | |
| Avg. volume | 292,561 |
| Market cap | 53.629M |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | 4.43 |
| EPS (TTM) | 0.2700 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.00 |
Business WireAVROBIO and Tectonic Therapeutic Announce Merger
CAMBRIDGE, Mass. & WATERTOWN, Mass., January 30, 2024--AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc. ("Tectonic"), a privately-held biotechnology company developing GPCR (G-protein coupled receptor)-targeted therapeutic proteins, co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School, today announced that the companies have entered into a definitive merger agreement to combine in an all-stock transaction (the "Merger"). Under the terms of the agreement, AVR
ZacksIs AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?
Here is how AVROBIO, Inc. (AVRO) and Crinetics Pharmaceuticals, Inc. (CRNX) have performed compared to their sector so far this year.
ZacksIs AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?
Here is how AVROBIO, Inc. (AVRO) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
